TransMedics Group Inc
Company Profile
Business description
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Contact
200 Minuteman Road
AndoverMA01810
USAT: +1 978 552-0900
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
728
Stocks News & Analysis
stocks
Qantas earnings: Jetstar capitalising on weaker domestic competition
stocks
Nvidia Earnings: No signs of a slowdown in demand for AI chips
stocks
ASX results reaction: WiseTech, Woolies, Sigma and more
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,168.00 | 7.10 | -0.08% |
| CAC 40 | 7,654.25 | 53.65 | -0.70% |
| DAX 40 | 23,487.33 | 550.00 | -2.29% |
| Dow JONES (US) | 45,215.51 | 329.37 | -0.72% |
| FTSE 100 | 9,116.69 | 79.65 | -0.87% |
| HKSE | 25,496.55 | 120.87 | -0.47% |
| NASDAQ | 21,214.36 | 241.20 | -1.12% |
| Nikkei 225 | 42,310.49 | 121.70 | 0.29% |
| NZX 50 Index | 13,133.16 | 62.71 | 0.48% |
| S&P 500 | 6,399.83 | 60.43 | -0.94% |
| S&P/ASX 200 | 8,900.60 | 1.50 | -0.02% |
| SSE Composite Index | 3,858.13 | 17.40 | -0.45% |